Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 11.12
Adjusted Patient Survival, Heart Transplants
Survival at 3 Months, 1 Year, 5 Years, and 10 Years
3 Months
1 Year
5 Years
10 Years
(Tx 2007 - 2008)
(Tx 2007 - 2008)
(Tx 2003 - 2008)
(Tx 1998 - 2008)
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
Total
All
4,067
93.6%
0.4%
4,067
89.0%
0.5%
11,958
75.2%
0.5%
22,473
56.4%
0.5%
Transplant Center State
Alabama
38
97.3%
2.6%
38
89.2%
5.0%
122
72.6%
4.6%
262
55.9%
4.1%
Arkansas
60
98.3%
1.6%
60
93.3%
3.2%
164
69.3%
4.3%
240
47.6%
6.0%
Arizona
90
93.6%
2.5%
90
90.4%
3.0%
243
75.0%
3.6%
384
58.6%
3.7%
California
514
94.8%
1.0%
514
90.4%
1.3%
1,501
79.0%
1.2%
2,704
58.0%
1.5%
Colorado
58
93.0%
3.4%
58
89.6%
4.0%
177
75.1%
3.6%
366
60.4%
3.4%
Connecticut
43
90.4%
4.5%
43
80.8%
6.0%
101
59.0%
5.9%
217
39.8%
4.7%
District of Columbia
7
85.6%
12.4%
7
85.6%
12.4%
39
80.0%
6.2%
74
65.2%
6.6%
Delaware
4
72.3%
20.7%
4
72.3%
20.7%
6
63.7%
18.6%
6
62.4%
19.0%
Florida
272
95.0%
1.3%
272
89.3%
1.8%
774
77.1%
1.8%
1,350
60.8%
2.0%
Georgia
86
91.9%
2.9%
86
87.2%
3.6%
240
69.5%
3.8%
447
54.9%
3.2%
Hawaii
3
100.0%
0.0%
3
69.4%
19.8%
7
62.0%
19.6%
17
45.4%
16.1%
Iowa
17
+
+
17
+
+
56
89.0%
4.7%
112
67.6%
5.9%
Illinois
162
95.7%
1.6%
162
92.0%
2.1%
428
72.3%
2.8%
767
56.9%
2.7%
Indiana
72
91.4%
3.3%
72
78.7%
4.9%
213
63.9%
4.0%
414
45.7%
3.6%
Kansas
13
77.7%
10.9%
13
77.7%
10.9%
40
77.2%
7.0%
68
41.1%
8.9%
Kentucky
35
87.7%
5.7%
35
84.6%
6.3%
136
71.7%
4.5%
297
47.1%
3.9%
Louisiana
41
93.3%
3.7%
41
86.5%
5.1%
145
71.7%
4.1%
428
52.2%
3.1%
Massachusetts
151
92.6%
2.1%
151
88.0%
2.7%
356
79.0%
2.9%
644
62.1%
2.8%
Maryland
81
88.8%
3.5%
81
80.1%
4.4%
194
72.8%
3.5%
307
52.5%
4.3%
Michigan
94
94.6%
2.3%
94
92.4%
2.7%
294
81.0%
2.6%
590
54.5%
3.1%
Minnesota
108
97.1%
1.6%
108
94.3%
2.3%
347
78.8%
2.6%
586
64.3%
3.0%
Missouri
168
91.4%
2.2%
168
85.3%
2.8%
429
75.0%
2.5%
766
54.0%
2.7%
Mississippi
17
+
+
17
+
+
49
65.4%
8.1%
107
54.4%
6.1%
North Carolina
158
93.1%
2.0%
158
89.9%
2.4%
462
71.6%
2.5%
878
52.2%
2.6%
Nebraska
25
96.1%
3.8%
25
92.2%
5.2%
52
77.6%
6.3%
84
39.2%
9.1%
New Jersey
91
96.8%
1.8%
91
92.4%
2.7%
259
81.1%
2.9%
413
53.1%
4.5%
New Mexico
0
-
-
0
-
-
0
-
-
18
55.3%
11.4%
New York
258
95.1%
1.3%
258
87.9%
2.0%
831
74.6%
1.7%
1,529
60.3%
1.8%
Ohio
170
92.2%
2.1%
170
87.4%
2.6%
573
76.4%
2.1%
1,224
55.1%
2.0%
Oklahoma
22
90.9%
6.0%
22
86.3%
7.2%
105
63.2%
5.5%
252
47.6%
4.1%
Oregon
34
93.8%
4.2%
34
90.7%
5.0%
110
79.9%
4.7%
229
63.9%
4.8%
Pennsylvania
341
93.1%
1.4%
341
88.3%
1.7%
974
74.7%
1.7%
1,909
55.5%
1.6%
Puerto Rico
20
+
+
20
+
+
74
77.7%
5.5%
108
58.6%
8.8%
South Carolina
39
94.6%
3.7%
39
91.9%
4.4%
115
78.5%
4.6%
228
64.8%
4.5%
Tennessee
96
87.7%
3.3%
96
83.6%
3.7%
290
74.5%
3.0%
586
51.5%
3.1%
Texas
357
93.8%
1.3%
357
89.7%
1.6%
1,027
69.4%
1.8%
1,889
53.0%
1.7%
Utah
65
98.4%
1.5%
65
96.9%
2.2%
198
82.5%
3.3%
336
63.8%
4.0%
Virginia
109
91.8%
2.6%
109
89.0%
3.0%
313
73.9%
2.9%
600
52.4%
3.0%
Washington
80
96.2%
2.1%
80
95.0%
2.4%
230
86.1%
2.6%
425
75.9%
2.8%
Wisconsin
68
83.5%
4.5%
68
80.5%
4.8%
284
76.6%
2.9%
612
58.9%
2.8%
Source: OPTN/SRTR Data as of October 1, 2010.
(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.
Cohorts are transplants performed during the years listed at the top of the table.
Patient survival follows patients from first transplant of this type until death.
Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.
Center volume = Center's yearly transplants performed during the base period, based on heart and heart-lung transplants.
Multi-organ transplants are excluded.
Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.